Alopecia areata during treatment with adalimumab: Therapy with an alternative TNF-alpha inhibitor is possible;Alopecia areata unter Therapie mit Adalimumab: Therapie mit alternativem TNF-alpha Inhibitor möglich

JDDG - Journal of the German Society of Dermatology

Volumn 11, Issue 5, 2013, Pages 450-454

  Zschoche, Carolin ^a   Bidier, Mona ^a   Hadaschik, Eva ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; ETANERCEPT; LEFLUNOMIDE; METHOTREXATE; STEROID;

ADULT; ALOPECIA; ALOPECIA AREATA; ARTHRALGIA; CASE REPORT; DISEASE COURSE; DRUG WITHDRAWAL; FEMALE; HUMAN; LETTER; PSORIASIS VULGARIS; PSORIATIC ARTHRITIS; PUVA; RECURRENT DISEASE; TREATMENT DURATION; UNSPECIFIED SIDE EFFECT;

ALOPECIA AREATA; ANTI-INFLAMMATORY AGENTS; ANTIBODIES, MONOCLONAL, HUMANIZED; ARTHRITIS, PSORIATIC; FEMALE; HUMANS; MIDDLE AGED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84877146122     PISSN: 16100379     EISSN: 16100387     Source Type: Journal    
DOI: 10.1111/ddg.12027     Document Type: Letter

References (10)

1. Wange E, McElwee KJ. Etiopathogenesis of alopecia areata: Why do our patients get it? Dermatologic Therapy 2011; 24: 33747.
2. Alexis AF, Dudda-Subramanya R, Sinha AA. Alopecia areata: autoimmune basis of hair loss. EJD 2004; 14: 36470.
3. Kasumagic-Halilovic E, Prohic A, Cavaljuga S. Tumor necrosis factor-alpha in patients with alopecia areata. Indian journal of dermatology 2011; 56: 494.
4. Pelivani N, Hassan AS, Braathen LR, Hunger RE, Yawalkar N. Alopecia areata universalis elicited during treatment with adalimumab. Dermatology 2008; 216: 32023.
5. Strober BE, Siu K, Alexis AF, Kim G, Washenik K, Sinha A, Shupack JL. Etanercept does not effectively treat moderate to severe alopecia areata: an open-label study. Journal of the American Academy of Dermatology 2005; 52: 108284.
6. Ettefagh L, Nedorost S, Mirmirani P. Alopecia areata in a patient using infliximab: new insights into the role of tumor necrosis factor on human hair follicles. Archives of dermatology 2004; 140: 1012.
7. Garcia Bartels N, Lee HH, Worm M, Burmester GR, Sterry W, Blume-Peytavi U. Development of alopecia areata universalis in a patient receiving adalimumab. Archives of dermatology 2006; 142: 1654.
8. Beccastrini E, Squatrito D, Emmi G, Fabbri P, Emmi L. Alopecia areata universalis during off-label treatment with Infliximab in a patient with Behet disease. Dermatology online journal 2010; 16: 15.
9. Ferran M, Calvet J, Almirall M, Pujol R, Maymó J. Alopecia areata as another immune-mediated disease developed in patients treated with tumour necrosis factor-? blocker agents. Journal of the European Academy of Dermatology and Venereology 2011; 25: 47984.
10. Le Bidre E, Chaby G, Martin L, Perrussel M, Sassolas B, Sigal M, Kaassis C, Lespessailles E, Nseir A, Estève E. Alopecia areata during anti-TNF alpha therapy: Nine cases 2011: 285.